- Home
- SCPQ vs COYA Comparison
SCPQ vs COYA Comparison
Compare SCPQ & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$3.78
Company Overview
Basic Information| Metric | SCPQ | COYA |
|---|---|---|
| Founded | 2025 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.5M | 126.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | SCPQ | COYA |
|---|---|---|
| Price | $9.90 | $3.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 842.0 | ★ 124.7K |
| Earning Date | 01-01-0001 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $820.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $9.86 | $3.91 |
| 52 Week High | $9.95 | $7.75 |
Technical Indicators
Market Signals| Indicator | SCPQ | COYA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 26.06 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $5.16 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 0.00 | 4.57 |
Price Performance
Historical Comparison SCPQ
COYA
About SCPQ Social Commerce Partners Corporation Class A Ordinary Shares
Social Commerce Partners Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.